Lepu Biopharma (2157.HK) announces 2025 interim results
HONG KONG, Aug 21, 2025 – (ACN Newswire via SeaPRwire.com) – Focusing on the field of tumor treatment, innovative biopharmaceutical company Lepu Biopharma Co., Ltd. (Lepu Biopharma or the Company, stock code: 2157.HK) announced its interim results for the first half of 2025. During the reporting period, the Company’s business showed strong growth momentum, achieving profitability […]